Final Form. As soon as practicable, a committee composed of an ETA representative and the Superintendent's designee will proofread and submit the document for publication but not later than forty-five (45) days after ratification, the new Agreement shall be available in an agreed upon format by ETA and the Board, with a table of contents including all appendices, and distributed to all members of the bargaining unit. Any additional cost of producing the contract shall be shared equally by the Board and the ETA.
Final Form. The Employer will prepare the final Agreement. As soon as practicable, but not later than forty-five (45) days after ratification, the Agreement shall be printed with a Table of Contents including all appendices, by the UniServ office. The Employer shall be provided thirty-five (35) additional copies for its use. The costs of printing shall be shared equally by the Board and the Association.
Final Form. Upon ratification of the Agreement by both parties, the Agreement shall be duplicated with a table of contents, including all appendices, in electronic form by the Board of Education at their expense and distributed to all certified personnel.
Final Form. When agreement is reached on the items being negotiated, a final written copy will be submitted to the Association for ratification and then to the Board at its next regular or special Board meeting. The final written copy will contain the following:
Final Form. The Subscriber understands that its investment in the Company will be subject to the terms and conditions of this Subscription Agreement and the other Company Documents in such final forms as shall be executed by the parties thereto Vista Credit Strategic Lending Corp. and as the same may be amended from time to time in accordance with their respective terms. The Subscriber further understands and acknowledges that certain of the terms and conditions of the Company and the Shares originally set forth in the Company’s Confidential Summary of Principal Terms and Conditions (as supplemented from time to time, the “Term Sheet”), summaries of certain terms provided by the Company or the Adviser and/or earlier drafts of the Company Documents may have been modified (and such documents may not be updated to reflect such modifications) and, as modified, will be reflected in the final form of the Company Documents.
Final Form. As soon as practicable following ratification of a Certificated/Licensed Fulltime and Part-time Teaching Personnel Negotiations Agreement, the Agreement shall be printed by the Board of Education and distributed to all personnel covered by the Agreement. The cost of printing shall be borne by the Board. The Association shall be permitted to copy the Agreement and all costs shall be the responsibility of the Association. The Board of Education and the Association shall furnish copies of the ratified Agreement to all organizations who may legally be required to have such copies.
Final Form. TRANSITION SERVICES AGREEMENT This Transition Services Agreement (this “Agreement”), dated as of [•] (the “Effective Date”), is by and between Crestwood Equity Partners LP, a Delaware limited partnership (“Parent”) and Oasis Petroleum LLC, a Delaware limited liability company (the “Sponsor”). Parent and the Sponsor are sometimes referred to individually as a “Party” and collectively as the “Parties.”
Final Form. As soon as practicable, but not later than forty-five (45) days after ratification, the Agreement shall be saved in a PDF file and placed in Staff shared drive for employee access only.
Final Form. As soon as practicable, but not later than sixty (60) days after ratification, the Agreement shall be printed with a Table of Contents including all appendices, in booklet form by the Board and distributed to all bargaining unit members. The Union shall be provided five (5) extra copies of the agreement.
Final Form. Sublicense and Distribution Agreement This Sublicense and Distribution Agreement (“Agreement”), dated and effective as of September [●], 2019 (the “Effective Date”), is by and among Razor Genomics Inc., a Delaware corporation (“Sublicensor”), OncoCyte Corporation, a California corporation (“Sublicensee”), and Encore Clinical, Inc., a Delaware corporation (“Encore”). Sublicensor, Sublicensee and Encore may be referred to herein collectively as the “Parties” or individually as a “Party”.
